The UK’s aspiration to be a global leader in life science and health technologies is one backed up by world-class research and innovation. Yet the pathway from medical technology conception to patient ...
NHS patients with type 2 diabetes (T2D) in England will get earlier access to SGLT-2 inhibitors, now that generics of one of the main drugs in the class – AstraZeneca's Forxiga – are available. Final ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results